Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/12088
Title: Modified horseshoe crab peptides target and kill bacteria inside host cells.
Authors: Amiss, Anna S
von Pein, Jessica B
Webb, Jessica R
Condon, Nicholas D
Harvey, Peta J
Phan, Minh-Duy
Schembri, Mark A
Currie, Bart J
Sweet, Matthew J
Craik, David J
Kapetanovic, Ronan
Henriques, Sónia Troeira
Lawrence, Nicole
Citation: © 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Cell Mol Life Sci. 2021 Dec 31. doi: 10.1007/s00018-021-04041-z.
Abstract: Bacteria that occupy an intracellular niche can evade extracellular host immune responses and antimicrobial molecules. In addition to classic intracellular pathogens, other bacteria including uropathogenic Escherichia coli (UPEC) can adopt both extracellular and intracellular lifestyles. UPEC intracellular survival and replication complicates treatment, as many therapeutic molecules do not effectively reach all components of the infection cycle. In this study, we explored cell-penetrating antimicrobial peptides from distinct structural classes as alternative molecules for targeting bacteria. We identified two β-hairpin peptides from the horseshoe crab, tachyplesin I and polyphemusin I, with broad antimicrobial activity toward a panel of pathogenic and non-pathogenic bacteria in planktonic form. Peptide analogs [I11A]tachyplesin I and [I11S]tachyplesin I maintained activity toward bacteria, but were less toxic to mammalian cells than native tachyplesin I. This important increase in therapeutic window allowed treatment with higher concentrations of [I11A]tachyplesin I and [I11S]tachyplesin I, to significantly reduce intramacrophage survival of UPEC in an in vitro infection model. Mechanistic studies using bacterial cells, model membranes and cell membrane extracts, suggest that tachyplesin I and polyphemusin I peptides kill UPEC by selectively binding and disrupting bacterial cell membranes. Moreover, treatment of UPEC with sublethal peptide concentrations increased zinc toxicity and enhanced innate macrophage antimicrobial pathways. In summary, our combined data show that cell-penetrating peptides are attractive alternatives to traditional small molecule antibiotics for treating UPEC infection, and that optimization of native peptide sequences can deliver effective antimicrobials for targeting bacteria in extracellular and intracellular environments.
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/34971427
Journal title: Cellular and molecular life sciences : CMLS
Publication Date: 2021-12-31
Type: Journal Article
URI: https://hdl.handle.net/10137/12088
DOI: 10.1007/s00018-021-04041-z
Orcid: 0000-0002-5365-875X
0000-0002-7233-7177
0000-0002-6332-039X
0000-0002-1833-1129
0000-0003-4735-6242
0000-0002-3426-1044
0000-0003-4863-9260
0000-0002-8878-8837
0000-0002-0406-8139
0000-0003-0007-6796
0000-0002-2908-1014
0000-0001-9564-9651
0000-0002-9013-1770
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing

Pubmed

PubMed References

Who's citing